ApoE ε4 allele is associated with incidental hallucinations and delusions in patients with AD

Neurology

Volumn 63, Issue 6, 2004, Pages 1105-1107

  Chang, J B ^a,b   Wang, P N ^a,b   Chen, W T ^a,c   Liu, C Y ^d   Hong, C J ^a,b   Lin, K N ^a,b,e   Liu, T Y ^a,b   Chi, C W ^a,b   Liu, Hsiu Chih ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c Chutung Veterans Hospital   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 4; UNCLASSIFIED DRUG; APOLIPOPROTEIN E4;

AGED; ALLELE; ALZHEIMER DISEASE; APOE EPSILON4 ALLELE; ARTICLE; CONTROLLED STUDY; DELUSION; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; HALLUCINATION; HAZARD ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRIORITY JOURNAL; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; INCIDENCE; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGICAL ASPECT; RISK;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; DELUSIONS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HALLUCINATIONS; HUMANS; INCIDENCE; MALE; PROPORTIONAL HAZARDS MODELS; RISK;

EID: 4644265043     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000138612.24301.32     Document Type: Article

References (10)

1. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
2. Teng EL, Hasegawa K, Homma A, et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 1994;6:45-58.
3. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;40:566-572.
4. Spitzer RL, Williams JBW, Gibbon M. Structured clinical interview for DSM-III-R (SCID). New York: New York State Psychiatric Institute, 1985.
5. Ramachandran G, Marder K, Tang M, et al. A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease. Neurology 1996;47:256-259.
6. Lopez OL, Kamboh MI, Becker JT, Kaufer DI, DeKosky ST. The apolipoprotein E ε4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease. Neurology 1997;49:794-797.
7. Hirono N, Mori E, Yasuda M, et al. Lack of effect of apolipoprotein E E4 allele on neuropsychiatric manifestations in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1999;11:66-70.
8. Scarmeas N, Brandt J, Albert M, et al. Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology 2002;58:1182-1188.
9. Soininen H, Kosunen O, Helisalmi S, et al. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele. Neurosci Lett 1995;187:79-82.
10. Bassiony MM, Lyketsos CG. Delusions and hallucinations in Alzheimer's disease: review of the brain decade. Psychosomatics 2003;44:388-401.